Hanmi Pharmaceutical (South Korea)
In research, Hanmi Pharmaceutical (South Korea) stands highest in Medicine (#7,724 of 10,443 worldwide) and Health Sciences (#9,582 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #22,636 of 28,054 · #36,064 all time
- Rank in South Korea
- #378 of 417
- Research works
- 292 ▲ 96% vs 2013–17
- Citations
- 3.5k 12.0 per fractional work
- Top-10% rate
- 8.7% record average 16.5%
- Open access
- 45% world 28%
What is Hanmi Pharmaceutical (South Korea) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,724 of 10,443 | 13.0% | 72 | #15301 | |
| Health SciencesDomain | #9,582 of 11,982 | 12.6% | 75 | #18102 |
Each strip is that field’s whole ranked pool, with the notch where Hanmi Pharmaceutical (South Korea) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.9×. Every wedge is a field page.
- Immunology and Microbiology 4.9×
- Biochemistry, Genetics and Molecular Biology 4.2×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 2.8×
- Nursing 2.5×
- Chemistry 1.1×
- Mathematics 0.8×
- Neuroscience 0.5×
- Computer Science 0.5×
- Agricultural and Biological Sciences 0.3×
- Materials Science 0.3×
- Economics, Econometrics and Finance 0.3×
- Decision Sciences 0.3×
- Environmental Science 0.2×
- Earth and Planetary Sciences 0.2×
- Health Professions 0.2×
- Engineering 0.2×
- Psychology 0.2×
- Business, Management and Accounting 0.1×
- Social Sciences 0.0×
- Dentistry 0.0×
Who are the top researchers at Hanmi Pharmaceutical (South Korea)?
Ranked on the composite score, Sojeong Park, Joo‐Yun Byun and Sungmin Bae lead among researchers whose main affiliation is Hanmi Pharmaceutical (South Korea).
- 1 Sojeong Park South Korea · #901,816 worldwide 25 citations · 21 works
- 2 Joo‐Yun Byun South Korea · #1,553,734 worldwide 6 citations · 23 works
- 3 Sungmin Bae South Korea · #1,614,090 worldwide 4 citations · 15 works
Which keywords describe research at Hanmi Pharmaceutical (South Korea)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Cancer Therapy, Tumor Microenvironment, Cell Proliferation, Heart Failure, Glycemic Control and Immunotherapy.
- Transcriptional Regulation
- Fc Receptors
- Tumor Suppression
- Diabetes Mellitus
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Monoclonal Antibodies
- Glycosylation
- Arginine Deprivation
- Gastric Cancer
- Innate Immunity
- Guidelines
- Diabetes
- Regulation
- Clinical Guidelines
- Chemotherapy
- Cell Proliferation
- Cardiovascular Disease
- Cancer Therapy
- Inflammation
- Cancer
- Epidemiology
- Tumor Microenvironment
- Immunotherapy
- Heart Failure
- Glycemic Control
- Insulin Therapy
- Gene Therapy
- Biomarkers
- Type 2 Diabetes
- Tumor Targeting
- Tumor Regression
- Bacterial Therapy
- Immunity
- Critical Care
- Mutation
- Cardiovascular Outcomes
- Glucose Control
- Gene Expression Regulation
- Therapeutic Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer11▲ 6.3×22 topics
- Inflammation11▲ 3.9×30 topics
- Epidemiology9▲ 1.72×45 topics
- Cancer Therapy7▲ 9.7×9 topics
- Tumor Microenvironment7▲ 12×6 topics
- Cardiovascular Disease6▲ 3.9×18 topics
- Immunotherapy5▲ 5.6×11 topics
- Cell Proliferation5▲ 43×3 topics
- Heart Failure5▲ 8.5×10 topics
- Chemotherapy5▲ 5.1×10 topics
- Glycemic Control5▲ 23×4 topics
- Clinical Guidelines4▲ 12×4 topics
- Insulin Therapy4▲ 28×3 topics
- Regulation4▲ 5.9×5 topics
- Gene Therapy4▲ 16×3 topics
- Diabetes4▲ 5.9×8 topics
- Biomarkers4▲ 4.2×8 topics
- Guidelines4▲ 6.0×7 topics
- Type 2 Diabetes4▲ 13×2 topics
- Innate Immunity4▲ 8.2×5 topics
- Tumor Targeting4▲ 15×2 topics
- Gastric Cancer3▲ 22×3 topics
- Tumor Regression3▲ 23×2 topics
- Arginine Deprivation3▲ 66×1 topic
- Bacterial Therapy3▲ 66×1 topic
- Glycosylation3▲ 21×2 topics
- Immunity3▲ 5.9×5 topics
- Monoclonal Antibodies3▲ 27×2 topics
- Critical Care3▲ 10×5 topics
- Immune Checkpoint Blockade3▲ 21×1 topic
- Mutation3▲ 12×4 topics
- PD-1 and PD-L13▲ 21×1 topic
- Cardiovascular Outcomes3▲ 41×1 topic
- Diabetes Mellitus3▲ 11×4 topics
- Glucose Control3▲ 41×1 topic
- Tumor Suppression3▲ 31×2 topics
- Gene Expression Regulation3▲ 20×2 topics
- Fc Receptors3▲ 39×1 topic
- Therapeutic Antibodies3▲ 30×1 topic
- Transcriptional Regulation3▲ 13×5 topics
Which research topics does Hanmi Pharmaceutical (South Korea) publish most on?
By volume in 2022–2025: Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Diabetes Treatment and Management and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Research and Treatments Biotechnology 3 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 3 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 5 RNA modifications and cancer Molecular Biology 2 works
- 6 Ubiquitin and proteasome pathways Molecular Biology 2 works
- 7 Helicobacter pylori-related gastroenterology studies Surgery 2 works
- 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 9 Cancer-related Molecular Pathways Oncology 2 works
- 10 Cancer-related gene regulation Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hanmi Pharmaceutical (South Korea)'s research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.